SHL TELEMEDICINE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.7 CHF | -9.62% |
|
-7.84% | -32.37% |
| May. 21 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Fresh Catalysts | MT |
| May. 21 | SHL Telemedicine Launches At-Home Blood Test for Heart Attack Detection in Israel | MT |
| Sales 2024 * | 62M 55.17M | Sales 2025 * | 75M 66.74M | Capitalization | 86.59M 77.05M |
|---|---|---|---|---|---|
| Net income 2024 * | -4M -3.56M | Net income 2025 * | - 0 | EV / Sales 2024 * | 1.4 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.15 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 583 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.95% |
More Fundamentals
* Assessed data
More news
Latest transcript on SHL Telemedicine Ltd.
More press releases
More news
| 1 day | -9.62% | ||
| 1 week | -7.84% | ||
| Current month | -9.62% | ||
| 1 month | +17.50% | ||
| 3 months | -12.96% | ||
| 6 months | -40.51% | ||
| Current year | -32.37% |
1 week
4.60
5.20
1 month
3.605.50
Current year
3.507.00
1 year
3.5010.90
3 years
3.5020.00
5 years
3.5020.00
10 years
3.5020.00
| Managers | Title | Age | Since |
|---|---|---|---|
Erez Nachtomy
CEO | Chief Executive Officer | 62 | 18-11-30 |
Amir Hai
DFI | Director of Finance/CFO | 58 | 21-12-31 |
Yossi Vadnagra
COO | Chief Operating Officer | - | 17-04-20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shuky Abramowitz
BRD | Director/Board Member | 63 | 17-06-27 |
Yariv Alroy
CEO | Chief Executive Officer | 63 | 99-12-31 |
Dvora Kimhi
BRD | Director/Board Member | - | 18-12-09 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-04 | 4.7 | -9.62% | 1,413 |
| 24-06-03 | 5.2 | 0.00% | 724 |
| 24-05-31 | 5.2 | +8.33% | 3,457 |
| 24-05-30 | 4.8 | -6.61% | 2,993 |
| 24-05-29 | 5.14 | +2.80% | 821 |
Delayed Quote Swiss Exchange, June 04, 2024 at 11:31 am EDT
More quotes
SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHLâs platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.
Calendar
2024-09-18
- Q2 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.37% | 95.15M | |
| +134.04% | 4.4B | |
| +78.57% | 584M | |
| +1.77% | 446M | |
| -73.82% | 125M |
- Stock Market
- Equities
- SHLTN Stock
